0001104659-16-113751.txt : 20160425 0001104659-16-113751.hdr.sgml : 20160425 20160425141056 ACCESSION NUMBER: 0001104659-16-113751 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160425 DATE AS OF CHANGE: 20160425 EFFECTIVENESS DATE: 20160425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 161588611 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 03-31-2016 03-31-2016 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger 415 801-8100 /s/ Robin L. Praeger San Francisco CA 04-22-2016 0 7 138515846 false INFORMATION TABLE 2 a16-8972_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 7822387 407416 SH OTR 0 407416 0 Five Prime Therapeutics, Inc. Common Stock 33830X104 44374135 1092152 SH OTR 0 1092152 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 1415611 1048601 SH OTR 0 1048601 0 Achaogen, Inc. Common Stock 004449104 3535979 1281152 SH OTR 0 1281152 0 Biotie Therapies Corp. ADS 09074D103 7090254 268672 SH OTR 0 268672 0 Ocular Therapeutix, Inc. Common Stock 67576A100 21400609 2215384 SH OTR 0 2215384 0 Glaukos Corporation Common Stock 377322102 52876871 3136232 SH OTR 0 3136232 0